Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 7:58 PM
Ignite Modification Date: 2025-12-24 @ 7:58 PM
NCT ID: NCT05263804
Eligibility Criteria: Inclusion Criteria: * Age ≥ 18 years * Ischemic Stroke confirmed by MRI * Proximal arterial occlusion (M1 and/or M2) * Eligible for thrombolysis and/or thrombectomy * Informed consent signed by the patient or the next of kin * Patient with a social security number Ancillary Study Inclusion Criteria: * Eligible for the Hibiscus stroke II cohort * Ancillary study informed consent signed by the patient or the next of kin Exclusion Criteria: * Patients for whom it is known at the inclusion that follow-up at 3 months will not be possible at Pierre Wertheimer Hospital (Lyon, France) * Patient with progressive or uncontrolled cancer. * Deprivation of civil rights * Pregnant woman or woman of childbearing age without proof of the absence of a current pregnancy * For patients participating in the optional fecal library: factors leading to a potential change in microbiota (antibiotic therapy within 3 months, probiotic or rebiotic use within 3 months, ileo or gastrostomy, gastrointestinal resection surgery, bariatric or peptic ulcer surgery, Crohn's disease or chronic inflammatory bowel disease, helicobacter pylori gastric ulcer less than 1 year old, participation in a study that aims to modify the microbiota) Ancillary Study Exclusion Criteria: * Contraindication to MRI with gadolinium injection * Contraindication to cardiac MRI (including inability to perform cardiac MRI) * Patients with a glomerular filtration rate \<30ml/min * History of coronary artery disease
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Study: NCT05263804
Study Brief:
Protocol Section: NCT05263804